|
HUP9902721A2
(hu)
*
|
1997-11-25 |
1999-12-28 |
The Procter & Gamble Co. |
Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
|
|
US6914057B1
(en)
|
1998-09-28 |
2005-07-05 |
The Research Foundation Of State University Of New York |
Inhibitor of cataract formation
|
|
CA2343038A1
(en)
*
|
1998-09-28 |
2000-04-06 |
Maria Emanuel Ryan |
A novel inhibitor of cataract formation
|
|
EP1385549A2
(en)
*
|
2001-03-12 |
2004-02-04 |
Novartis AG |
Combination of nateglinide or repaglinide with at least one further antidiabetic compound
|
|
EP1383483A4
(en)
*
|
2001-04-05 |
2006-08-09 |
Collagenex Pharm Inc |
CONTROLLED RELEASE OF TETRACYCLIN COMPOUNDS AND TETRACYCLINE DERIVATIVES
|
|
FR2826278B1
(fr)
*
|
2001-06-20 |
2005-03-25 |
Lipha |
Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
|
|
EP1397124B1
(fr)
*
|
2001-06-20 |
2006-11-29 |
Merck Sante |
Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
|
|
EP2332547A1
(en)
|
2001-07-13 |
2011-06-15 |
Paratek Pharmaceuticals, Inc. |
Tetracyclines for the treatment of inflammatory bowel disease
|
|
WO2003059253A2
(en)
*
|
2001-12-21 |
2003-07-24 |
Smithkline Beecham Corporation |
Compositions and methods for altering glucose production
|
|
EP2311798A1
(en)
|
2002-01-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
|
WO2003075857A2
(en)
|
2002-03-08 |
2003-09-18 |
Paratek Pharmaceuticals, Inc. |
Amino-methyl substituted tetracycline compounds
|
|
CA2479877C
(en)
|
2002-03-21 |
2012-08-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
AU2003261161B2
(en)
|
2002-07-12 |
2009-09-10 |
Paratek Pharmaceuticals, Inc |
3, 10, and 12a substituted tetracycline compounds
|
|
CA2521885C
(en)
|
2003-04-07 |
2013-06-25 |
Shire Laboratories, Inc. |
Once daily formulations of tetracyclines
|
|
EP1656341A1
(en)
|
2003-07-09 |
2006-05-17 |
Paratek Pharmaceuticals, Inc. |
Prodrugs of 9-aminomethyl tetracycline compounds
|
|
WO2005009943A2
(en)
|
2003-07-09 |
2005-02-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
EP2332904A3
(en)
|
2004-01-15 |
2012-04-11 |
Paratek Pharmaceuticals, Inc. |
Derivatives of tetracycline compounds
|
|
EP2301916A3
(en)
|
2004-10-25 |
2011-09-28 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
|
EP2269978A3
(en)
|
2004-10-25 |
2011-09-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
US20070093455A1
(en)
*
|
2005-07-21 |
2007-04-26 |
Paul Abato |
10-substituted tetracyclines and methods of use thereof
|
|
US20070098763A1
(en)
*
|
2005-10-11 |
2007-05-03 |
Sinnott Robert A |
Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
|
|
IL270446B2
(en)
|
2006-12-21 |
2023-10-01 |
Paratek Pharm Innc |
A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
|
|
EP2120963B1
(en)
|
2006-12-21 |
2018-09-12 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds for treatment of inflammatory skin disorders
|
|
EP2213655A1
(en)
*
|
2007-04-27 |
2010-08-04 |
Paratek Pharmaceuticals, Inc. |
Methods For Purifying Aminoalkyl Tetracycline Compounds
|
|
EA201070233A1
(ru)
*
|
2007-07-06 |
2010-08-30 |
Паратек Фармасьютикалс, Инк. |
Способы синтеза замещённых соединений тетрациклина (варианты)
|
|
TW202332671A
(zh)
*
|
2008-05-19 |
2023-08-16 |
美商Ｐｒｔｋ Ｓｐｖ２公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
|
CN105367440A
(zh)
|
2008-08-08 |
2016-03-02 |
四相制药公司 |
C7-氟取代的四环素化合物
|
|
CN102459153A
(zh)
|
2009-05-08 |
2012-05-16 |
四相制药公司 |
四环素类化合物
|
|
HUE037852T2
(hu)
|
2009-08-28 |
2018-09-28 |
Tetraphase Pharmaceuticals Inc |
Tetraciklin-vegyületek
|
|
PL2552890T3
(pl)
|
2010-03-31 |
2017-07-31 |
Tetraphase Pharmaceuticals, Inc. |
Policykliczne związki tetracyklinowe
|
|
EA031523B1
(ru)
|
2012-08-31 |
2019-01-31 |
Тетрафейз Фармасьютикалс, Инк. |
Тетрациклиновые соединения
|
|
US9897565B1
(en)
|
2012-09-11 |
2018-02-20 |
Aseko, Inc. |
System and method for optimizing insulin dosages for diabetic subjects
|
|
US9171343B1
(en)
|
2012-09-11 |
2015-10-27 |
Aseko, Inc. |
Means and method for improved glycemic control for diabetic patients
|
|
US9486580B2
(en)
|
2014-01-31 |
2016-11-08 |
Aseko, Inc. |
Insulin management
|
|
US9898585B2
(en)
|
2014-01-31 |
2018-02-20 |
Aseko, Inc. |
Method and system for insulin management
|
|
EP3933845A3
(en)
|
2014-10-27 |
2022-06-22 |
Aseko, Inc. |
Subcutaneous outpatient management
|
|
US11081226B2
(en)
|
2014-10-27 |
2021-08-03 |
Aseko, Inc. |
Method and controller for administering recommended insulin dosages to a patient
|
|
JP6858751B2
(ja)
|
2015-08-20 |
2021-04-14 |
アセコー インコーポレイテッド |
糖尿病管理療法アドバイザ
|
|
HRP20240605T1
(hr)
|
2016-10-19 |
2024-07-19 |
Tetraphase Pharmaceuticals, Inc. |
Kristalni oblici eravaciklina
|
|
US12570604B2
(en)
|
2018-11-09 |
2026-03-10 |
Tetraphase Pharmaceuticals, Inc. |
Polymorphic forms of a tetracycline compound and uses thereof
|
|
EP3968785A4
(en)
|
2019-05-14 |
2023-01-11 |
Tyme, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
|
|
EP4132561A4
(en)
*
|
2020-04-08 |
2024-04-24 |
Hoffman Technologies LLC |
METHODS OF TREATING INSULIN DEFICIENCY CONDITIONS IN ANIMALS
|
|
US10905698B1
(en)
|
2020-05-14 |
2021-02-02 |
Tyme, Inc. |
Methods of treating SARS-COV-2 infections
|